. Prognostic value of serum IL-2, IFN-γ, TNF-α, IL-6, and IL-8, IL-10 in elderly Patients underwent Thoracotomy
Prognostic value of serum IL-2, IFN-γ, TNF-α, IL-6, and IL-8, IL-10
Abstract
Objective: To investigate the effect of different fluid therapy on TH1 and TH2 cytokines ( IL-2, IFN-γ, TNF-α, IL-6, and IL-8 , IL-10 ) during perioperative period of thoracotomy in elderly patients.
Methods:A total of 60 elderly patients who underwent thoracotomy from January 2022 to April 2024 were divided into the control group (CG) and the observation group (OG), with 30 cases in each group. The CG received routine fluid management, while the OG received goal-directed fluid management. The postoperative recovery status, fluid intake and output, hemodynamic indexes, TH1 and TH2 cytokine levels were compared between both groups.
Results: The postoperative extubation time, drainage time, ICU stayand hospitalization time in the OG were reduced than those in the CG (P<0.05). The urine volume, crystalloid volume, colloid volume and total volume of fluid in the OG werereduced than those in the CG (P<0.05). At 1 h after surgery (T2), the HR and MAP levels of the two groups were reduced than those before surgery (T1) (P<0.05); at the end of surgery (T3), the HR and MAP of the CG were raised than those at T1 (P<0.05); at T2, the HR and MAP levels in the OG were raised than those in the CG (P<0.05); at T3, the HR and MAP levels in the OG were reduced than those in the CG (P<0.05). 1 day after operation, the levels ofIL-2, IFN-γ, TNF-α, IL-6, and IL-8 were raised than those before surgery, (P<0.05), and the levels of IL-10 wasreduced than those before treatment (P<0.05).
Conclusion: Perioperative goal-directed fluid therapy for elderly patients with thoracotomy is beneficial to maintain perioperative hemodynamic stability, improve serum levels of TH1 and TH2 cytokines, reduce the body's inflammatory response, and facilitate early postoperative recovery.
References
[2] Ulger G, Baldemir R. Comparison of Patient-Controlled Analgesia With Tramadol or Morphine After Video-Assisted Thoracoscopic Surgery in Geriatric Patients. Cureus. 2021 Dec 28;13(12):e20781.
[3] Liu X, Zhang P, Liu MX, et al. Preoperative carbohydrate loading and intraoperative goal-directed fluid therapy for elderly patients undergoing open gastrointestinal surgery: a prospective randomized controlled trial. BMC Anesthesiol. 2021 May 21;21(1):157.
[4] Ali-Osman F, Mangram A, Sucher J, et al. Geriatric (G60) trauma patients with severe rib fractures: Is muscle sparing minimally invasive thoracotomy rib fixation safe and does it improve post-operative pulmonary function? Am J Surg. 2018 Jul;216(1):46-51.
[5] Haas S, Eichhorn V, Hasbach T, et al. Goal-directed fluid therapy using stroke volume variation does not result in pulmonary fluid overload in thoracic surgery requiring one-lung ventilation. Crit Care Res Pract. 2012;2012:687018.
[6] Chong MA, Wang Y, Berbenetz NM, et al. Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis. Eur J Anaesthesiol. 2018 Jul;35(7):469-483.
[7] Joosten A, Coeckelenbergh S, Alexander B, et al. Hydroxyethyl starch for perioperative goal-directed fluid therapy in 2020: a narrative review. BMC Anesthesiol. 2020 Aug 20;20(1):209.
[8] Aaen AA, Voldby AW, Storm N, et al. Goal-directed fluid therapy in emergency abdominal surgery: a randomised multicentre trial. Br J Anaesth. 2021 Oct;127(4):521-531.
[9] Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev. 2019 Dec 12;12(12):CD012767.
[10] Gopal J, Srivastava S, Singh N, et al. Pulse Pressure Variance (PPV)-Guided Fluid Management in Adult Patients Undergoing Supratentorial Tumor Surgeries: A Randomized Controlled Trial. Asian J Neurosurg. 2023 Sep 22;18(3):508-515.
[11] McLain N, Parks S, Collins MJ. Perioperative Goal-Directed Fluid Therapy: A Prime Component of Enhanced Recovery After Surgery. AANA J. 2021 Aug;89(4):351-357.
[12] Joosten A, Van der Linden P, Vincent JL, et al. Goal-directed fluid therapy for oesophagectomy surgery. Br J Anaesth. 2021 Feb;126(2):e54-e55.
[13] Wang X, Wang N, Wang X, et al. Application value of goal-directed fluid therapy with ERAS in patients undergoing radical lung cancer surgery. Am J Transl Res. 2021 Jul 15;13(7):8186-8192.
[14] Wang X, Duan Y, Gao Z, et al. Effect of Goal-directed Fluid Therapy on the Shedding of the Glycocalyx Layer in Retroperitoneal Tumour Resection. J Coll Physicians Surg Pak. 2021 Oct;31(10):1179-1185.
[15] Xu H, Shu SH, Wang D, et al. Goal-directed fluid restriction using stroke volume variation and cardiac index during one-lung ventilation: a randomized controlled trial. J Thorac Dis. 2017 Sep;9(9):2992-3004.
[16] Obradovic M, Kurz A, Kabon B, et al. The effect of intraoperative goal-directed crystalloid versus colloid administration on perioperative inflammatory markers - a substudy of a randomized controlled trial. BMC Anesthesiol. 2020 Aug 21;20(1):210.
[17] Zhang N, Liang M, Zhang DD, et al. Effect of goal-directed fluid therapy on early cognitive function in elderly patients with spinal stenosis: A Case-Control Study. Int J Surg. 2018 Jun;54(Pt A):201-205.
[18] Wodack KH, Poppe AM, Tomkötter L, et al. Individualized early goal-directed therapy in systemic inflammation: is full utilization of preload reserve the optimal strategy? Crit Care Med. 2014 Dec;42(12):e741-51.
[19] Funk DJ, HayGlass KT, Koulack J, et al. A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair. Crit Care. 2015 Jun 10;19(1):247.
Copyright (c) 2025 Ling Li

This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
